By contrast, other chemokine axes, such as the CXCL12‐CXCR4/ACKR3 pathway, are protumourigenic as they promote cancer proliferation, angiogenesis, metastasis and/or chemotherapy resistance [7]. This evidence concerns the gene CXCR4 and cancer.